entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
101926967,ATXN7L3-AS1,lncRNA,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,7.58452152098994,0.0739243107351319,0.723495459518562,0.102176606311149,0.918616496017228,0.994998021163286,NA
101926967,ATXN7L3-AS1,lncRNA,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,34.9807624024253,-0.284813573240916,0.319415384224691,-0.89167143258374,0.372569069943355,0.93503189972122,patient-derived GBM cell lines (PDGCLs)
101926967,ATXN7L3-AS1,lncRNA,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,67.5726215831612,-0.0451734088262055,0.263043528665556,-0.171733587423247,0.863646979133921,0.951396133987456,A549
101926967,ATXN7L3-AS1,lncRNA,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,39.0714662012025,-0.0246811232625606,0.316606636756204,-0.077955167066083,0.937863715910505,0.986418245486816,A549
101926967,ATXN7L3-AS1,lncRNA,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,8.2972312423675,-2.0075341483645,1.11647477941744,-1.79810075908029,0.072161041980556,0.187650669117422,A549
101926967,ATXN7L3-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,36.4287106080701,-0.460911510496445,0.292275053166535,-1.57697862168833,0.114800444237573,1,sigmoid colon organoid
101926967,ATXN7L3-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,36.4287106080701,-0.491810419029027,0.291899774914958,-1.6848605627473,0.0920154769362611,0.619916321302341,sigmoid colon organoid
